The impact of the stromal cell-derived factor-1-3′A and E-selectin S128R polymorphisms on breast cancer

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 43-50

  Kontogianni, Panagiota ^a   Zambirinis, Constantinos P ^a,b   Theodoropoulos, George ^a   Gazouli, Maria ^c   Michalopoulos, Nikolaos V ^a   Flessas, John ^a   Liberi, Maria ^c   Zografos, George C ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Breast cancer; CXCL12; E selectin; Polymorphisms; S128R; SDF 1 3 A; Stromal cell derived factor 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; E-SELECTIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84871346108     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1989-x     Document Type: Article

References (35)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France
2. American Cancer Society (2010) Cancer Facts & Figures2010. American Cancer Society, Atlanta
3. Polyak K (2007) Breast cancer: origins and evolution. J Clin Invest 117(11):3155-3163. doi: 10.1172/JCI33295
4. Tang P, Skinner KA, Hicks DG (2009) Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol 18(3):125-132. doi: 10.1097/PDM.0b013e31818d107b
5. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127(4):679-695. doi: 10.1016/j.cell.2006.11.001
6. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121-127
7. Vagima Y, Lapid K, Kollet O, Goichberg P, Alon R, Lapidot T (2011) Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol 750:277-289. doi: 10.1007/978-1-61779-145-1-19
8. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50-56. doi: 10.1038/35065016
9. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279(5349):389-393
10. Theodoropoulos GE, Panoussopoulos GS, Michalopoulos NV, Zambirinis CP, Taka S, Stamopoulos P, Gazouli M, Zografos G (2010) Analysis of the stromal cell-derived factor 1-3′A gene polymorphism in pancreatic cancer. Mol Med Rep 3(4):693-698. doi: 10.3892/mmr-00000319
11. Laubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20(3):169-177. doi: 10.1016/j.semcancer.2010.04.005
12. Petruzzelli L, Takami M, Humes HD (1999) Structure and function of cell adhesion molecules. Am J Med 106(4):467-476
13. Somers WS, Tang J, Shaw GD, Camphausen RT (2000) Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103(3):467-479
14. Sperandio M, Gleissner CA, Ley K (2009) Glycosylation in immune cell trafficking. Immunol Rev 230(1):97-113. doi: 10.1111/j.1600-065X.2009.00795.x
15. Gout S, Morin C, Houle F, Huot J (2006) Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 66(18):9117-9124. doi: 10.1158/0008-5472.CAN-05-4605
16. Wenzel K, Hanke R, Speer A (1994) Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet 94(4):452-453
17. Revelle BM, Scott D, Beck PJ (1996) Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem 271(27):16160-16170
18. Edge SB, American Joint Committee on Cancer (2010) AJCC cancer staging manual. 7th edn. Springer, New York
19. Panoussopoulos GS, Theodoropoulos G, Michalopoulos NV, Gazouli M, Flessas J, Taka S, Stamopoulos P, Manouras A, Zografos GC (2010) Analysis of E-selectin S128R gene polymorphism in pancreatic cancer. J Surg Oncol 102(6):604-607. doi: 10.1002/jso.21648
20. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I (1996) Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 183(2):581-587
21. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG (2005) Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7(4):R402-R410. doi: 10.1186/bcr1022
22. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121(3):335-348. doi: 10.1016/j.cell.2005. 02.034
23. Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 65(15):6493-6497. doi: 10.1158/0008-5472.CAN-04- 1303
24. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86(12):1221-1232. doi: 10.1038/labinvest.3700482
25. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G, Sica A (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198(9):1391-1402. doi: 10.1084/jem.20030267
26. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4(7):540-550. doi: 10.1038/nrc1388
27. Zafiropoulos A, Crikas N, Passam AM, Spandidos DA (2004) Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41(5):e59
28. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A (2005) Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 225(2):261-266. doi: 10.1016/j.canlet.2004.10.039
29. Hassan S, Baccarelli A, Salvucci O, Basik M (2008) Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 14(2):446-454. doi: 10.1158/1078-0432.CCR-07-1189
30. Miles FL, Pruitt FL, van Golen KL, Cooper CR (2008) Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 25(4):305-324. doi: 10.1007/s10585-007-9098-2
31. Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9(12):874-885. doi: 10.1038/nrc2761
32. Renkonen J, Paavonen T, Renkonen R (1997) Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 74(3):296-300. doi: 10.1002/(SICI)1097-0215(19970620)74: 3<296:AID-IJC11>3.0.CO;2-A
33. Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM (2011) Selectin ligand sialyl-Lewis×antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 71(24):7683-7693. doi: 10.1158/0008-5472.CAN-11-1139
34. Hebbar M, Adenis A, Revillion F, Duhamel A, Romano O, Truant S, Libersa C, Giraud C, Triboulet JP, Pruvot FR, Peyrat JP (2009) E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Eur J Cancer 45(10):1871-1876. doi: 10.1016/j.ejca.2009.03. 011
35. Naidu R, Har YC, Taib NA (2011) Polymorphic variant Ser128Arg of E-selectin is associated with breast cancer risk and high grade tumors. Onkologie 34(11):592-597. doi: 10.1159/000334060